Bausch Health Companies Inc
TSX:BHC
Bausch Health Companies Inc
TSX:BHC
Price:
8.95 CAD
4.19%
Market Closed
Updated:
May 31, 2024
Bausch Health Companies Inc
Cash Equivalents
|
Bausch Health Companies Inc
Cash Equivalents Peer Comparison
Comparables:
WEED
CRON
C
CURA
T
TER
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash Equivalents
$733m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash Equivalents
CA$55.1m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash Equivalents
$855.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash Equivalents
$118.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Cash Equivalents
$26.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bausch Health Companies Inc's Cash Equivalents?
Cash Equivalents
733m
USD
733m
USD
Based on the financial report for Mar 31, 2024, Bausch Health Companies Inc's Cash Equivalents amounts to 733m USD.
What is Bausch Health Companies Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
2%
2%
Over the last year, the Cash Equivalents growth was 42%. The average annual Cash Equivalents growth rates for Bausch Health Companies Inc have been 3% over the past three years , -1% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
